HEB, Hemispherx BioPharma, Inc.

** HEB reported that ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, has approved the sale and distribution of Alferon N Injection(R) (under the brand name "Naturaferon") in Argentina.

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $69.63 where it was opened at $69.10 up 0.43 points or +0.62% by closing at $69.57.

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $66.45 where it was opened at $65.26 up 0.73 points or +1.11% by closing at $66.40.